Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Mbio|November 29, 2024
The protein composition of human adenovirus replication compartmentsPaloma Hidalgo, Amada Torres, Pierre M Jean Beltran, et al.
Antiviral Research|April 7, 2020
The trimeric artesunate derivative TF27 exerts strong anti-cytomegaloviral efficacy: Focus on prophylactic efficacy and oral treatment of immunocompetent miceMarkus Wild, Luca D Bertzbach, Pierre Tannig, et al.
Frontiers in Genome Editing|October 29, 2021
Acquiring Resistance Against a Retroviral Infection via CRISPR/Cas9 Targeted Genome Editing in a Commercial Chicken LineRomina Hellmich, Hicham Sid, Kamila Lengyel, et al.
Journal of Virology|November 2, 2023
Adenovirus E1B-55K controls SUMO-dependent degradation of antiviral cellular restriction factorsWing-Hang Ip, Michael H Tatham, Steewen Krohne, et al.
Frontiers in Immunology|June 13, 2022
The Diverse Major Histocompatibility Complex Haplotypes of a Common Commercial Chicken Line and Their Effect on Marek's Disease Virus Pathogenesis and TumorigenesisLuca D Bertzbach, Clive A Tregaskes, Rebecca J Martin, et al.
Microorganisms|June 2, 2021
A Genetically Engineered Commercial Chicken Line Is Resistant to Highly Pathogenic Avian Leukosis Virus Subgroup JAhmed Kheimar, Romina Klinger, Luca D Bertzbach, et al.
Journal of Virology|November 17, 2021
Conserved E1B-55K SUMOylation in Different Human Adenovirus Species Is a Potent Regulator of Intracellular LocalizationViktoria Kolbe, Wing H Ip, Lisa Kieweg-Thompson, et al.
International Journal of Molecular Sciences|January 12, 2021
Combinatorial Drug Treatments Reveal Promising Anticytomegaloviral Profiles for Clinically Relevant Pharmaceutical Kinase Inhibitors (PKIs)Markus Wild, Jintawee Kicuntod, Lisa Seyler, et al.
Antiviral Research|November 20, 2018
In vivo proof-of-concept for two experimental antiviral drugs, both directed to cellular targets, using a murine cytomegalovirus modelEric Sonntag, Friedrich Hahn, Luca D Bertzbach, et al.
Cell Reports|July 28, 2021
Development of safe and highly protective live-attenuated SARS-CoV-2 vaccine candidates by genome recodingJakob Trimpert, Kristina Dietert, Theresa C Firsching, et al.
Pageof 7